Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1200795

CLEMASTINE FUMARATE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O

Basic Information

ChEMBL ID CHEMBL1200795
Name CLEMASTINE FUMARATE
Phase Approved
Structure Type MOL
InChI Key PMGQWSIVQFOFOQ-YKVZVUFRSA-N
Therapeutic ✓ Yes
Parent Compound CHEMBL1626
Active Moiety CHEMBL1626

Known Names

Clemastine fumarate Clemastine fumarate component of tavist-d Clemastine hydrogen fumarate Tavegil Tavist Tavist-1
6
Targets
16
Activities
1
Assay Types
0
PK Parameters
20
Publications
6
Known Names
8
Indications
1
Mechanisms

Molecular Properties

343.9
MW (Da)
5.10
ALogP
2
HBA
0
HBD
12.5
PSA (Ų)
0.72
QED
1
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1977
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral
USAN Stem -astine
USAN Year 1977

Extended Properties

Molecular Formula C25H30ClNO5
MW 459.97
Aromatic Rings 2
Heavy Atoms 24
NP-Likeness -0.40

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Histamine H1 receptor antagonist ANTAGONIST Histamine H1 receptor

Indications

Common Cold Rhinitis, Allergic Rhinitis, Allergic, Seasonal Urticaria Hypersensitivity Multiple Sclerosis Multiple Sclerosis, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting

Activity Summary

IC50 16 meas. best 6.34

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Plasmodium falciparum
CHEMBL364
IC50 6.34 5.5022 456.0 9
Plasmodium berghei
CHEMBL612653
IC50 6.02 6.02 951.0 1
SARS-CoV
CHEMBL4303836
IC50 5.94 5.94 1153.0 1
Middle East respiratory syndrome-related coronavirus
CHEMBL4296578
IC50 5.87 5.87 1343.0 1
Plasmodium
CHEMBL4888483
IC50 5.66 5.66 2200.0 1
SARS-CoV-2
CHEMBL4303835
IC50 5.65 5.2 2245.0 3

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Plasmodium falciparum IC50 = 456.0 nM 6.34 HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection 22586124
Plasmodium falciparum IC50 = 658.0 nM 6.18 HARVARD: Inhibition of blood stage Plasmodium falciparum 3D7 infection 22586124
Plasmodium berghei IC50 = 951.0 nM 6.02 HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells 22586124
SARS-CoV IC50 = 1153.0 nM 5.94 Antiviral activity against pseudovirus SARS-CoV-1 spike glycoprotein infected hu... 34394844
Middle East respiratory syndrome-related coronavirus IC50 = 1343.0 nM 5.87 Antiviral activity against pseudovirus MERS-CoV spike glycoprotein infected huma... 34394844
Plasmodium IC50 = 2200.0 nM 5.66 Antimalarial activity against Plasmodium 32283298
SARS-CoV-2 IC50 = 2245.0 nM 5.65 Antiviral activity against pseudovirus SARS-CoV-2 spike glycoprotein infected hu... 34394844
Plasmodium falciparum IC50 = 2511.89 nM 5.6 Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR gr... 19734910
Plasmodium falciparum IC50 = 3981.07 nM 5.4 Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR g... 19734910
Plasmodium falciparum IC50 = 5011.87 nM 5.3 Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR g... 19734910
Plasmodium falciparum IC50 = 5011.87 nM 5.3 Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR g... 19734910
Plasmodium falciparum IC50 = 5011.87 nM 5.3 Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR g... 19734910
Plasmodium falciparum IC50 = 7943.28 nM 5.1 Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR g... 19734910
SARS-CoV-2 IC50 = 7900.0 nM 5.1 Antiviral activity against SARS COV-2 infected in African green monkey Vero E6 c... 34394844
Plasmodium falciparum IC50 = 10000.0 nM 5.0 Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR g... 19734910
SARS-CoV-2 IC50 = 14100.0 nM 4.85 Antiviral activity against pseudovirus SARS-CoV-2 spike protein infected in HEK2... 34394844

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL4689842 Fibroblast 345
- 10.6019/CHEMBL4689842 HEK-293T 345
- 10.6019/CHEMBL4689842 U2OS 343
19734910 10.1038/nchembio.215 Plasmodium falciparum 7
- 10.6019/CHEMBL5209801 Free fatty acid receptor 4 5
- 10.6019/CHEMBL5209801 N-formyl peptide receptor 2 5
- 10.6019/CHEMBL5209801 C5a anaphylatoxin chemotactic receptor 1 5
34394844 10.1021/acsmedchemlett.1c00263 SARS-CoV-2 5
- 10.6019/CHEMBL5209801 Type-1 angiotensin II receptor 5
- 10.6019/CHEMBL5209801 Adhesion G-protein coupled receptor F1 5
- 10.6019/CHEMBL5209801 CX3C chemokine receptor 1 5
- 10.6019/CHEMBL5209801 Beta-2 adrenergic receptor 5
- 10.6019/CHEMBL5209801 Alpha-2A adrenergic receptor 5
- 10.6019/CHEMBL5209801 Glucagon-like peptide 1 receptor 5
- 10.6019/CHEMBL5209801 Glucose-dependent insulinotropic receptor 5
- 10.6019/CHEMBL5209801 Sphingosine 1-phosphate receptor 1 5
- 10.6019/CHEMBL5209801 Apelin receptor 5
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
22586124 10.1073/pnas.1118370109 Plasmodium falciparum 2
- 10.6019/CHEMBL5209801 G-protein coupled receptor 35 2

Data from ChEMBL 36 via Core Engine